Clinical Trial Update: Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

This Phase 1 trial tests a triple-drug regimen of Revumenib, azacitidine, and venetoclax in pediatric and young adult patients with refractory or relapsed acute…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Leukemia of Ambiguous Lineage

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Revumenib (revumenib)
• Venetoclax (venetoclax)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Refractory Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING